Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction

Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction

Background Whether heart failure with preserved ejection fraction (HFpEF) is associated with an increased risk of developing systolic dysfunction and a poor prognosis in hypertrophic cardiomyopathy (HCM) patients is unknown. Objective We aimed to assess risk factors for the development of end-stage...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical research in cardiology 2024-05, Vol.113 (5), p.761-769
Hauptverfasser: Chen, Qin-Fen, Hu, Jiandong, Hu, Jie, Nijjar, Prabhjot S., Xu, Jiahui, Shi, Shanzhen, Liang, Dongjie, Liao, Hetong, Gao, Jiaqi, Lin, Wei-Hong, You, Shenban, Zhou, Xiao-Dong
Format: Artikel
Sprache:eng
Schlagworte:
Abbreviations
Cardiology
Cardiomyopathy
Cardiomyopathy, Hypertrophic - complications
Congestive heart failure
Echocardiography
Ejection fraction
Heart Failure
Humans
Medicine
Medicine & Public Health
Original Paper
Phenotypes
Prognosis
Retrospective Studies
Risk assessment
Risk factors
Stroke Volume
Tachycardia
Ventricular Function, Left
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Whether heart failure with preserved ejection fraction (HFpEF) is associated with an increased risk of developing systolic dysfunction and a poor prognosis in hypertrophic cardiomyopathy (HCM) patients is unknown. Objective We aimed to assess risk factors for the development of end-stage (ES) heart failure (HF) (ejection fraction 
ISSN:1861-0684
1861-0692
DOI:10.1007/s00392-023-02371-5